TG Therapeutics Inc vs Valero Energy Corporation — how do they compare? TG Therapeutics Inc trades at $54 (market cap $8.26B), while Valero Energy Corporation trades at $314.47 (market cap $93.03B). The key difference: Valero Energy Corporation is far larger — about 11.3× TG Therapeutics Inc's market cap, and Valero Energy Corporation pays a 1.53% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| TGTX | VLO | |
|---|---|---|
Market Cap | $8.26B | $93.03B |
Sector | Health | Energy |
52-Week High | $59.06 | $313.31 |
52-Week Low | $26.39 | $131.77 |
Enterprise Value | $8.50B | $98.79B |
Dividend Yield | — | 1.53% |
Trailing returns across standard periods
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →